FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1858268736> ?p ?o ?g. }

• W1858268736 endingPage "562" @default.
• W1858268736 startingPage "556" @default.
• W1858268736 abstract "We investigated the vitamin D status of patients receiving frequently used types of combination antiretroviral therapy (cART), including boosted protease inhibitor (PI) monotherapy.For this cross-sectional study, out of 450 HIV-infected patients followed in the Hospital Severo Ochoa (Madrid, Spain), we selected 352 patients for whom vitamin D levels had been measured (January 2009 to December 2010). We collected the following data: demographics, cART duration, main cART regimen, viral load (VL), CD4 cell count, and concentrations of 25(OH)-vitamin D [25(OH)-D], parathyroid hormone (PTH), albumin and calcium. Vitamin D status cut-off points were: (1) deficiency (vitDd): 25(OH)-D < 20 ng/mL; (2) insufficiency (vitDi): 25(OH)-D from 20 to 29.99 ng/mL; and (3) optimal (vitDo): 25(OH)-D ≥ 30 ng/mL.The percentages of patients with vitDd, vitDi and vitDo were 44, 27.6 and 28.5%, respectively. Twenty-nine out of 30 (96.7%) Black patients had vitDd or vitDi, vs. 71.6% in the global sample (P < 0.001). Former injecting drug users (IDUs) had a higher prevalence of vitDo (P < 0.001) than patients in other transmission categories. Among patients with vitDd, vitDi and vitDo, the proportions of patients with a VL ≤ 50 HIV-1 RNA copies/mL were 77.4, 68 and 91%, respectively (P < 0.0001). Of the cART regimens, only boosted PI monotherapy was associated with significant differences in vitamin D levels (P = 0.039). Multivariate logistic regression analysis showed an increased risk of vitDi or vitDd associated with the following variables: Black vs. Caucasian ethnicity [odds ratio (OR) 10.6; 95% confidence interval (CI) 1.2-94; P = 0.033]; heterosexual (OR 2.37; 95% CI 1.13-4.93; P = 0.022) or men who have sex with men (MSM) (OR 3.25; 95% CI 1.25-8.50; P = 0.016) transmission category vs. former IDU; and VL > 50 copies/mL (OR 2.56; 95% CI 1.10-7.25; P = 0.040). A lower risk of vitamin D insufficiency or deficiency was found in patients on boosted PI monotherapy vs. no treatment (OR 0.08; 95% CI 0.01-0.6; P = 0.018).Our data show an increased risk of vitamin D deficiency or insufficiency in patients with detectable VL and a Black ethnic background. Among cART regimens, boosted PI monotherapy was associated with a lower risk of vitamin D deficiency or insufficiency. The more favourable vitamin D status in former IDUs was probably attributable to a higher frequency of outdoor jobs in this group of patients." @default.
• W1858268736 created "2016-06-24" @default.
• W1858268736 creator A5026071692 @default.
• W1858268736 creator A5064873706 @default.
• W1858268736 creator A5065663817 @default.
• W1858268736 creator A5066368590 @default.
• W1858268736 creator A5073384702 @default.
• W1858268736 creator A5074375510 @default.
• W1858268736 creator A5079415776 @default.
• W1858268736 date "2013-06-05" @default.
• W1858268736 modified "2023-10-04" @default.
• W1858268736 title "Higher vitamin D levels in HIV-infected out-patients on treatment with boosted protease inhibitor monotherapy" @default.
• W1858268736 cites W1965950196 @default.
• W1858268736 cites W1970359693 @default.
• W1858268736 cites W1972526543 @default.
• W1858268736 cites W1980266637 @default.
• W1858268736 cites W1981215835 @default.
• W1858268736 cites W1983613770 @default.
• W1858268736 cites W1990608803 @default.
• W1858268736 cites W1996563641 @default.
• W1858268736 cites W2003293061 @default.
• W1858268736 cites W2018006483 @default.
• W1858268736 cites W2025740330 @default.
• W1858268736 cites W2034103388 @default.
• W1858268736 cites W2051605499 @default.
• W1858268736 cites W2055697791 @default.
• W1858268736 cites W2064837363 @default.
• W1858268736 cites W2069851825 @default.
• W1858268736 cites W2075458382 @default.
• W1858268736 cites W2114323760 @default.
• W1858268736 cites W2120716047 @default.
• W1858268736 cites W2124070987 @default.
• W1858268736 cites W2155638837 @default.
• W1858268736 cites W2161933674 @default.
• W1858268736 cites W2171153361 @default.
• W1858268736 doi "https://doi.org/10.1111/hiv.12049" @default.
• W1858268736 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/23738846" @default.
• W1858268736 hasPublicationYear "2013" @default.
• W1858268736 type Work @default.
• W1858268736 sameAs 1858268736 @default.
• W1858268736 citedByCount "21" @default.
• W1858268736 countsByYear W18582687362015 @default.
• W1858268736 countsByYear W18582687362016 @default.
• W1858268736 countsByYear W18582687362017 @default.
• W1858268736 countsByYear W18582687362018 @default.
• W1858268736 countsByYear W18582687362019 @default.
• W1858268736 countsByYear W18582687362021 @default.
• W1858268736 countsByYear W18582687362023 @default.
• W1858268736 crossrefType "journal-article" @default.
• W1858268736 hasAuthorship W1858268736A5026071692 @default.
• W1858268736 hasAuthorship W1858268736A5064873706 @default.
• W1858268736 hasAuthorship W1858268736A5065663817 @default.
• W1858268736 hasAuthorship W1858268736A5066368590 @default.
• W1858268736 hasAuthorship W1858268736A5073384702 @default.
• W1858268736 hasAuthorship W1858268736A5074375510 @default.
• W1858268736 hasAuthorship W1858268736A5079415776 @default.
• W1858268736 hasBestOaLocation W18582687361 @default.
• W1858268736 hasConcept C124490489 @default.
• W1858268736 hasConcept C126322002 @default.
• W1858268736 hasConcept C127413603 @default.
• W1858268736 hasConcept C142462285 @default.
• W1858268736 hasConcept C144024400 @default.
• W1858268736 hasConcept C149923435 @default.
• W1858268736 hasConcept C151956035 @default.
• W1858268736 hasConcept C203014093 @default.
• W1858268736 hasConcept C2777275308 @default.
• W1858268736 hasConcept C2779740938 @default.
• W1858268736 hasConcept C2780084366 @default.
• W1858268736 hasConcept C2781413609 @default.
• W1858268736 hasConcept C3013748606 @default.
• W1858268736 hasConcept C71924100 @default.
• W1858268736 hasConcept C78519656 @default.
• W1858268736 hasConcept C90924648 @default.
• W1858268736 hasConceptScore W1858268736C124490489 @default.
• W1858268736 hasConceptScore W1858268736C126322002 @default.
• W1858268736 hasConceptScore W1858268736C127413603 @default.
• W1858268736 hasConceptScore W1858268736C142462285 @default.
• W1858268736 hasConceptScore W1858268736C144024400 @default.
• W1858268736 hasConceptScore W1858268736C149923435 @default.
• W1858268736 hasConceptScore W1858268736C151956035 @default.
• W1858268736 hasConceptScore W1858268736C203014093 @default.
• W1858268736 hasConceptScore W1858268736C2777275308 @default.
• W1858268736 hasConceptScore W1858268736C2779740938 @default.
• W1858268736 hasConceptScore W1858268736C2780084366 @default.
• W1858268736 hasConceptScore W1858268736C2781413609 @default.
• W1858268736 hasConceptScore W1858268736C3013748606 @default.
• W1858268736 hasConceptScore W1858268736C71924100 @default.
• W1858268736 hasConceptScore W1858268736C78519656 @default.
• W1858268736 hasConceptScore W1858268736C90924648 @default.
• W1858268736 hasIssue "9" @default.
• W1858268736 hasLocation W18582687361 @default.
• W1858268736 hasLocation W18582687362 @default.
• W1858268736 hasOpenAccess W1858268736 @default.
• W1858268736 hasPrimaryLocation W18582687361 @default.
• W1858268736 hasRelatedWork W2042777717 @default.
• W1858268736 hasRelatedWork W2047402106 @default.
• W1858268736 hasRelatedWork W2150788336 @default.
• W1858268736 hasRelatedWork W2503404095 @default.

• next